Written questions by Chope.

How many patients were registered at (a) Highcliffe Medical Centre, (b) Christchurch Medical Centre, (c) Burton Brunch Surgery, (d) Stour Surgery and (e) The Grove Surgery on (i) 1 June 2024 and (ii) 14 May 2025.

The data below shows the number of registered patients at the Highcliffe Medical Centre, the Christchurch Medical Practice, the Stour Surgery, and the Grove Medical Centre as of 31 March 2025, as this is the most recent available data, and as of 31 March 2024, to align with the most recent data.Data for the Burton Medical Centre is not available as it was a branch of the Christchurch Medical Practice. The Burton Medical Centre became a branch practice in October 2017 and was subsequently closed in October 2024. The following table shows the number of registered patients at the Highcliffe Medical Centre, the Christchurch Medical Practice, the Stour Surgery, and the Grove Medical Centre as of 31 March 2025: Practice nameTotal patientsHighcliffe Medical Centre15,308Christchurch Medical Practice16,303Stour Surgery10,684The Grove Medical Centre12,978 In addition, the following table shows the number of registered patients at the Highcliffe Medical Centre, the Christchurch Medical Practice, the Stour Surgery, and the Grove Medical Centre as of 31 March 2024: Practice nameTotal patientsHighcliffe Medical Centre15,153Christchurch Medical Practice16,938Stour Surgery10,399The Grove Medical Centre13,016

What information his Department holds on the number of (a) face-to-face and (b) other GP appointments conducted at (i) Highcliffe Medical Centre, (ii) Christchurch Medical Centre, (iii) Burton Branch Surgery (iv) The Stour Surgery and (v) The Grove Surgery in (A) 2022-23, (B) 2023-24 and (C) 2024-25.

A table showing the number of face-to-face and other general practice appointments conducted for the Highcliffe Medical Centre, the Christchurch Medical Centre, the Stour Surgery, and the Grove Surgery is attached. Data for the Burton Medical Centre is not available as it was a branch of the Christchurch Medical Practice. The Burton Medical Centre became a branch practice in October 2017, and was subsequently closed in October 2024.

With reference to his oral contribution in response to the hon. Member for Christchurch of 25 March 2025, Official Report, column 773, whether he has received an update from the Dorset Integrated Care Board about the Burton Branch Surgery application.

The NHS Dorset Integrated Care Board (ICB) has received applications to open a branch surgery in the Village of Burton, near Christchurch in Dorset. Applications are currently going through the ICB governance process, which is expected to conclude following the ICB Prevention, Equity and Outcomes Committee on 23 April.Following a local practice closure in August 2024, the ICB is assessing capacity in the area, which remains good. Access to general practice (GP) services for local residents remains very good, with a choice of five practices in the Christchurch area that are all accepting new patients and growing their lists. The NHS Dorset ICB is engaging with local partners, other GP practices, and the Wessex Local Medical Committees to ensure views are collated while going through our governance processes.

How many patients at the Great Western Hospital in Swindon died from hospital acquired pneumonia in (a) December 2024, (b) January 2025 and (c) February 2025.

10 patients died from hospital acquired pneumonia at the Great Western Hospital in Swindon in December 2024. Figures for January 2025 and February 2025 cannot be provided until May 2025.

Pursuant to the Answer of 1 April 2025 to Question 41384, what the (a) maximum and (b) minimum time was between a Vaccine Damage Payment Scheme application being made to the NHS Business Services Authority and being submitted to Crawford & Co for review.

The submission of applications to Crawford & Co is dependent on the NHS Business Services Authority (NHSBSA) receiving the relevant medical records from healthcare providers.As of 3 April 2025, the maximum time between an application being made to the Vaccine Damage Payment Scheme and that application being submitted to Crawford & Co for review was 1,339 days. The minimum time was 14 days, and the average time was 199 days.The NHSBSA is working with healthcare providers to speed up the rate at which these medical records are shared.

What was the (a) maximum and (b) minimum time between Crawford & Co completing a medical review of applications for vaccine damage payments and the applicant being informed of the decision in in the period January 2024 – December 2024.

Between January and December 2024, the maximum time between Crawford & Co completing a medical assessment of an application to the Vaccine Damage Payment Scheme and the applicant being informed by the NHS Business Services Authority of my Rt Hon. Friend, the Secretary of State for Health and Social Care’s decision as to whether they are entitled to a payment under the scheme was 518 days. The minimum time was zero days, with the claimants informed of the outcome on the same day that the medical assessment was completed.Over the same period, the average time between Crawford & Co completing a medical assessment of an application and the applicant being informed of my Rt Hon. Friend, the Secretary of State for Health and Social Care’s decision was 14 days.

When he plans to reply to the correspondence of 5 February 2025 from the hon. Member for Christchurch relating to a constituent.

We have received the Hon. Member’s correspondence of 5 February 2025, and we will respond shortly.

Pursuant to the Answer of 24 March 2025 to Question 39387 on Vaccine Damage Payment Scheme, if he will make an estimate of the number of assessments that have missed the 95 per cent target; how many of those have been delayed by more than (a) one, (b) six and (c) 12 months; and whether penalties have been imposed on Crawford & Company for missed deadlines.

Between January 2024 and December 2024, the percentage of medical assessment reports returned within 15 working days of receipt of a fully completed medical record was 99.8%. In the same period, 10 medical assessment reports were not returned within the 15-day timeframe. Of these, nine reports were returned within a month, with one report delayed by more than a month. No medical assessment reports were delayed either by more than six or 12 months.The supplier has previously had service credits applied as a result of not returning medical assessment reports to the NHS Business Services Authority within 15 working days. As the supplier has achieved above 95% in relation to this target since August 2023, no service credits have been applied since 2023.

Pursuant to the Answer of 24 March to Question 39386 on NHS Business Services Authority: Crawford & Company, how much of the budget of £38.6m is set aside for the payment of VDPS claims; and what the forecast is for the number of applications to the VDPS to be processed by Crawford & Co for 2025-26.

For the 2025/26 financial year, the budget allocated for the Vaccine Damage Payment Scheme is £38.6 million. The forecasted amount within this budget for vaccine damage payments is approximately £9 million. The budget for the 2025/26 financial year is based on estimates that approximately 8,500 assessments, including mandatory reversals, will be carried out in 2025/26.The budget allocated for payments has no bearing on the outcomes of individual assessments. The NHS Business Services Authority will request additional funding from the Department to process additional claims if needed, for example if the number of claims received is more than forecasted.

For what reason applicants seeking mandatory reversal of decisions made by the NHSBSA on vaccine damage claims are required as a precondition to adduce fresh evidence without which no mandatory reversal is possible; and whether there is statutory provision for such a restriction.

If a claimant to the Vaccine Damage Payment Scheme (VDPS) wants to challenge a decision about their claim, they can ask for the decision to be reviewed. This is known as a ‘mandatory reversal’.In accordance with the legislation which governs the VDPS, when applying for a mandatory reversal, claimants must provide an explanation of why they think that the original decision is wrong, and they may provide further evidence to support their request. They can also ask the NHS Business Services Authority, the administrators of the VDPS, to request additional medical records from healthcare providers.However, providing further evidence to support their request for a mandatory reversal is not a legal or operational requirement. The answer given by the Department to PQ39388 incorrectly stated that claimants must provide additional evidence to their claim before a mandatory reversal is undertaken. This response has been corrected.

For what services the NHSBSA paid Crawford & Co; and what the budget for expenditure on the services of Crawford & Co is for the Vaccine Damage Payment Scheme for 2025-26.

Crawford & Company currently provides a medical assessment service for the Vaccine Damage Payment Scheme (VDPS). The VDPS budget for 2025/26, including payments to claimants, the budget for Crawford & Company, and the budget for the operation of the scheme by the NHS Business Services Authority, is £38.6 million. Final expenditure by Crawford & Company will depend on a number of variables, including the number of claims received.

With reference to his Department's contract entitled Medical Assessments: Vaccine Damage Payment Scheme, procurement reference, CF-0724900D0O000000rwimUAA, whether Crawford & Company are required to respond to Vaccine Damage Payment Scheme claims within a specified time period; and whether they receive rewards on account of the speed of assessments.

The length of time it takes to process a Vaccine Damage Payment Scheme (VDPS) claim varies from case to case. This is because medical records will often be gathered from claimants’ healthcare providers before a claim undergoes medical assessment, and receiving a claimant’s records can take time.95% of the assessments that are shared with an independent medical assessor should be returned to the VDPS administrators, the NHS Business Service Authority, within 15 working days. Sometimes this can take longer because medical assessments are complex, and these medical assessors will review individual medical records, which can be thousands of pages.No rewards are provided within the contract.

If he will make an estimate of the number of Vaccine Damage Payment Scheme claims on Covid-19 vaccinations which have been accepted following mandatory reversal based upon (a) additional evidence provided and (b) existing evidence.

Claimants to the Vaccine Damage Payment Scheme (VDPS) can ask for a reassessment, known as a mandatory reversal, if they disagree with the decision on the eligibility of their claim. Additional evidence can be added before it is reassessed, and this can include medical records.Between 1 November 2021, when the NHS Business Services Authority took over administration of the VDPS, and 20 March 2025, 25 claims have been awarded a Vaccine Damage Payment following a mandatory reversal. Additional evidence was provided for all of these claims.Claims without additional evidence are received and reassessed through the mandatory reversal process. However, no claims without additional evidence have been awarded a Vaccine Damage Payment.

When the application by the South Coast Medical Group for the establishment of a surgery in Burton as a Branch of The Grove Surgery was made; and when a decision will be given.

The Department does not hold information on applications for the establishment of new surgeries as it is for integrated care boards, as part of their commissioning responsibility for primary care, to consider applications for any new general practice surgeries.The hon. Member may wish to raise this issue with the local integrated care board directly, so it can investigate this further. Their contact details at available at the following link:https://www.nhs.uk/nhs-services/find-your-local-integrated-care-board/

How many Vaccine Damage Payment Scheme (VDPS) medical assessors are in post; and how many assessors have left since the roll-out of the VDPS to covid-19 vaccinations.

The number of medical assessors is managed by a third-party supplier and varies depending on the volume of claims received, as well as the volume of medical records received from healthcare providers. Since COVID-19 was added to the Vaccine Damage Payment Act 1979, the number of medical assessors assessing claims has significantly increased.

What training medical assessors of applications to the Vaccine Damage Payment Scheme relating to covid-19 vaccinations receive; what qualifications are needed to become such an assessor; what continuing professional development requirements must such assessors meet; whether such assessors are required to work in-person and not remotely; and to what supervision are such assessors subject.

Medical assessments are carried out by an independent, third-party supplier. The supplier manages the medical assessors' training and work arrangements, organises for each medical assessment to be peer reviewed by another medical assessor, and is responsible for ensuring that medical assessors continue their professional development.All medical assessors are General Medical Council (GMC) registered doctors with a license to practise and a minimum of five years' post graduate experience. They are held to strict professional standards set by the GMC and, in addition to their five years’ post graduate experience, assessors must have experience of undertaking a medical and/or disability assessment, and of addressing questions of causation and impact in the context of legislative or policy requirements.

How many applications to the Vaccine Damage Payment Scheme relating to covid-19 vaccinations have been subject to a request for mandatory reversal; how many and what proportion of such requests (a) were rejected and (b) have been outstanding for more than (i) three, (ii) six and (iii) 12 months; and how many and what proportion of rejected requests were referred to the First-Tier Tribunal.

As of 27 February 2025, 1,657 applications to the Vaccine Damage Payment Scheme relating to COVID-19 vaccinations have been subject to a request for mandatory reversal. Re-assessment has been completed for 1,073 of these applications, with 21, or 2% of, decisions reversed. A reversal does not mean that the original decision was incorrect, as claimants provide additional information during the mandatory reversal process which can alter the outcome of the assessment.Of the outstanding claims, 333, or 20% of the total mandatory reversal applications, have been outstanding for more than three months. Of those, 200, or 12%, have been outstanding for more than six months, and of those 81, or 5%, have been outstanding for more than 12 months. 69, or 7% of, rejected mandatory reversals have been referred to the First-Tier Tribunal.

What tribunal decisions have been used by the NHS Business Services Authority to assess claims relating to Covid-19 vaccinations under the Vaccine Damage Payment Scheme.

Since taking over administration of the Vaccine Damage Payment Scheme on 1 November 2021, all decisions taken by the NHS Business Services Authority that have been appealed to tribunal have been upheld.Decisions in first tier tribunals do not set a precedent for other cases. All claims to the Vaccine Damage Payment Scheme are assessed on a case-by-case basis, using the latest available medical evidence. Medical assessors will consider the claim form, medical records from the vaccinated person’s healthcare providers, clinical research, epidemiological evidence, and the current consensus of expert medical opinion.

How much his Department has indemnified Astrazeneca in relation to covid-19 vaccine damage claims.

The Government cannot comment on the terms on which COVID-19 vaccinations were procured, which are confidential.

With reference to paragraph 20 of his Department's Opening Statement to Module 4 of the UK Covid-19 Inquiry, published 15 January 2025, what estimate his Department has made of the number of (a) deaths, (b) infections and (c) hospitalisations that were prevented by the covid-19 vaccination programme since September 2021.

The estimated total averted hospitalisations, severe hospitalisations, and deaths for the spring and autumn 2023 boosters were:- 1,654 hospitalisations, 108 severe, and 508 deaths for the spring 2023 booster program in those aged 75 years old and over; and- 7,054 hospitalisations, 473 severe, and 1,862 deaths for the autumn 2023 booster program in those aged 65 years old and over.This can be found in the COVID-19 vaccine surveillance report week 29, which is available at the following link: https://assets.publishing.service.gov.uk/media/669923b20808eaf43b50d1fd/Vaccine_surveillance_report_2024_week_29.pdf In total, an estimated 14,400 hospitalisations were averted in adults aged 50 years old and older in England as a result of the vaccination from the autumn 2022 COVID-19 vaccine booster programme. This information is in the COVID-19 vaccine surveillance report week 41, which is available at the following link: https://assets.publishing.service.gov.uk/media/6527f0bfaea2d0000d219c69/vaccine-surveillance-report-2023-week-41.pdf These are a direct effect calculation and do not include any additional cases prevented from herd immunity. They also do not include cases averted where COVID-19 exacerbated a non-respiratory condition that led to hospitalisation. In total, an estimated 18,600 hospitalisations, based on cases reported through the Sari-Watch surveillance scheme, were averted in adults aged 50 years old and older in England as a result of vaccination from the autumn 2021 COVID-19 vaccine booster programme. Further information can be found on the GOV.UK website, at the following link: https://assets.publishing.service.gov.uk/media/62c6c2168fa8f54e855dfe29/Vaccine-surveillance-report-week-27.pdf This was also a direct effect calculation method.